Tumor-specific killer cells in paraneoplastic cerebellar degeneration
- 1 November 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 4 (11), 1321-1324
- https://doi.org/10.1038/3315
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cancer Tumor antigensCurrent Opinion in Immunology, 1997
- Dendritic Cells as Adjuvants for Immune-mediated Resistance to TumorsThe Journal of Experimental Medicine, 1997
- A Post-Transcriptional Regulatory Mechanism Restricts Expression of the Paraneoplastic Cerebellar Degeneration Antigen cdr2 to Immune Privileged TissuesJournal of Neuroscience, 1997
- Improved methods for the generation of dendritic cells from nonproliferating progenitors in human bloodJournal of Immunological Methods, 1996
- Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.Proceedings of the National Academy of Sciences, 1996
- Paraneoplastic cerebellar degeneration.Neurology, 1992
- Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration.Proceedings of the National Academy of Sciences, 1991
- Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti‐neuronal cell antibody from a patient with paraneoplastic cerebellar degenerationAnnals of Neurology, 1990
- Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromesNeurology, 1990
- Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration.Proceedings of the National Academy of Sciences, 1987